LUTS was the most common indication for TURP in recent years.

The clinical efficacy of PK-TURP is long-lasting and comparable with M-TURP.

Also, bipolar-TURP costs in patients with large-volume prostates had rather similar costs to RASP.

The annual cases of TURP increased over the study period.

Conclusion: Yunnan Baiyao is effective on reducing the amount of intraoperative bleeding of TURP without side effect.

Outcomes compared favourably with TURP, with lower peri-operative morbidity and equally low occurrence of late adverse effects.

For TURP, a single-dose antimicrobial prophylaxis (AP) is recommended to reduce postoperative urinary tract infections.

No differences were detected in safety outcomes except that the clot retention rate was significantly greater after M-TURP.

Discussion: For AP in TURP and GL, there is a large gap between usual clinical practice and evidence-based guidelines.

Conclusions: TURP has been steadily performed in patients with benign prostatic hyperplasia and it is expected to remain constant.

Moreover, all micturition parameters in the TmLRP-TT group were similar to those of TURP patients at every annual assessment.

Preliminary experience suggests that it may be a viable alternative to TURP and appears to have some significant advantages.

However, TURP still holds the steadier long-term results and is more effective to reduce obstruction as well as other LUTS.

We also aimed to compare IPSS score improvements between the PAE and TURP groups, using non-inferiority analysis on propensity-score-matched patient pairs.

Among these surgical treatments, TUVP by thick-loop was recognized as being second choice to TURP with regard to efficacy and overall usefulness.

Genomic DNA obtained from TURP derived specimens showed no difference in size or enzyme digestibility in comparison to that from open prostatectomy.